Harvard has frozen the reduction of its position in Bitcoin ETFs: a strategic pause or a shift in priorities?
Harvard University's endowment fund, one of the most influential institutional players in the market, has shown unexpected restraint in managing its crypto portfolio. According to the latest 13F filing submitted to the SEC, as of June 30, the fund retained 3.04 million shares of BlackRock's bitcoin ETF IBIT, valued at $101.4 million. This is exactly the same as the previous quarter, signaling the end of an aggressive selling phase.
Two quarters of reductions behind
It is important to emphasize the context: prior to this, Harvard had consistently trimmed its exposure to the bitcoin ETF for two consecutive reporting periods. At the end of 2025, the position was cut by 21%, and in the first quarter of 2026, by another 43%. The current pause looks like a deliberate strategic halt rather than a coincidence. It appears that at current price levels, the management team decided to lock in the remaining volume without risking further reductions ahead of a potential surge.
Gold dominates, but bitcoin holds its ground
More telling is the comparison with traditional safe-haven assets. Harvard's investments in gold exchange-traded funds now significantly exceed its crypto allocation: $171.2 million versus $101.4 million, respectively. This reflects a global trend among institutional investors — amid macroeconomic uncertainty, they prefer time-tested protection over a volatile digital asset. Nevertheless, the very fact of maintaining a $100+ million position in IBIT suggests that a complete exit from the market is not being considered.
My analysis: Harvard's pause is a classic "wait-and-see" signal. The fund does not believe in an imminent collapse, but it is also not ready to increase risk. For the market, this is rather a neutral sign: institutional money remains in the game, but their risk appetite has cooled. The key question is what happens next quarter: if bitcoin shows sustained growth above key levels, we may see a new wave of buying, and if not, Harvard may resume reductions, but from a lower base.